Appointments at Icon, Quintiles, Catalent and CRF Health – People on the move

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Icon, Quintiles, Catalent and CRF Health.

Elizabeth Thomas has been named vice president (VP) and general manager of Icon’s bioanalytical operations in Manchester, UK. Thomas joins from AstraZeneca and has also worked at Quintiles and Covance during a 30 year career in bioanalysis.

Quintiles has made three appointments to its European consulting team. Peter Lassoff joins as practice leader of the European Union (EU) pharmaceutical regulatory and quality practice. Lassoff has previously worked at Parexel, Stiefel Laboratories and Bristol-Myers Squibb.

Ines Weizenegger, formerly of Executive Insight, has been hired as senior consultant for the EU commercial effectiveness practice. Finally, Olaf Zorzi joins the Quintiles consulting team from Deloitte.

Catalent Pharma Solutions has appointed Harry Jeffreys as VP, quality management systems and compliance. Jeffreys joins from the medical diagnostics division at GE Healthcare.

Mary Foster has been named VP of quality and regulatory affairs at Aphena Pharma Solutions. Foster has worked in the sector for 25 years, most recently at Catalent Pharma Solutions.

Irvine Pharmaceutical Services has recruited Dorla Mirejovsky as senior director of formulation development. Mirejovsky has 25 years of experience from working at Spectrum Pharmaceuticals, Allergan and more.

John Larson has been named chief operating officer at CRF Health. Larson joins from Medtronic and has also worked at Philips Medical Systems and Agfa Healthcare.

Cegedim Relationship Management has hired Mark Caverly as senior DEA (US Drug Enforcement Administration) regulatory consultant. Caverly worked at the DEA for 31 years.

Paul Shawah has joined Veeva Systems as VP of multichannel strategy. Shawah has worked in life sciences for more than 15 years, most recently as VP of the SAP Life Sciences Business Unit.